Research News and Research

RSS

Study finds Medicare doesn't pay adequately for clot-busting stroke treatment

Treating stroke patients with clot-busting drugs costs U.S. hospitals substantially more than Medicare pays, a new study finds.

18 Jan 2012

Innovative computer algorithm identifies clinically prognostic marker for cancer

Researchers at the Stanford University School of Medicine have used an innovative mathematical technique to find markers that effectively predict how deadly a cancer will be. The discovery, which in this case concerned bladder cancer, could lead to faster, less expensive and more accurate analysis of cancer risk and better treatment of the disease.

18 Jan 2012

New path for individually tailored cancer therapy

The Institute of Translational Oncology (TRON) together with BioNTech AG today announced the publication of a joint paper in the international journal Cancer Research that describes a new path for individually tailored cancer therapy.

18 Jan 2012

With new poll showing low public approval, Congress returns to D.C.:'Doc fix,' tax cuts on agenda

The Associated Press reports that in order to prevent a 27 percent cut in Medicare payments to doctors, negotiators are trying to find $39 billion in cuts elsewhere in health spending. A deal could be reached faster than initially expected.

18 Jan 2012

Alnylam sues Tekmira over LNP-formulated siRNA molecules

Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that it has filed a patent infringement lawsuit against Tekmira Pharmaceuticals Corporation in the U.S. District Court of the District of Massachusetts.

18 Jan 2012

Research reports on effectiveness of Scriptaid in breast cancer cell lines

Although endocrine therapy for breast cancer has shown excellent results in controlling the disease, responsiveness to the therapy depends on whether or not there is expression of estrogen receptors in breast cancer cells. Research from the Sbarro Institute for Cancer Research and Molecular Medicine, a nonprofit cancer, cardiovascular and diabetes research center located in Philadelphia, PA, reports on the effectiveness of a new molecule, Scriptaid, that restores receptivity to endocrine therapy in breast cancer cell lines that had tested negative for the expression of estrogen receptors.

18 Jan 2012

Study compares adoptive T-cell therapy with drug-based cancer treatment

In the treatment of large tumors, how effective is adoptive T cell therapy in comparison to drug-based cancer treatment? To answer this question, Dr. Kathleen Anders and Professor Thomas Blankenstein of the Max Delbr-ck Center for Molecular Medicine (MDC) Berlin-Buch and researchers of the Beckman Research Institute of the City of Hope Cancer Center in Duarte, California, USA designed and carried out a study comparing the two methods. Based on a mouse cancer model, the researchers elucidated the mechanisms of the two different treatments.

18 Jan 2012

Teenagers more susceptible to addiction and depression

Teenagers are more susceptible to developing disorders like addiction and depression, according to a paper published by Pitt researchers Jan. 16 in the Proceedings of the National Academy of Sciences.

18 Jan 2012

Food insecurity forces families to 'stretch' infant formula

Despite receiving supplemental food benefits, some families cannot afford enough infant formula and resort to the dangerous practice of formula "stretching" - watering down formula - to feed their babies, according to a Cincinnati Children's Hospital Medical Center study conducted at urban pediatric clinics.

18 Jan 2012

Afghan President Karzai urges Taliban to allow polio vaccination teams into insurgent-controlled areas

Afghanistan President Hamid Karzai on Tuesday "urged the Taliban to allow teams conducting a polio vaccination campaign access to areas under their control" and "said that whoever hampers the medical workers 'is the enemy of our children's future,'" the Associated Press/Washington Post reports.

18 Jan 2012

Voraxaze receives FDA approval for treatment of toxic methotrexate levels

The U.S. Food and Drug Administration today approved Voraxaze (glucarpidase) to treat patients with toxic levels of methotrexate in their blood due to kidney failure.

18 Jan 2012

State roundup: State lawmakers, governors planning health legislation; Some Pa. kids losing Medicaid

Iowa House and Senate Republicans could support legislation requiring lawmakers to contribute to the cost of their state-provided health-care benefits, party leaders told the Des Moines Register's editorial board this morning. The health-care packages now offered by the state - in which most employees, including legislators, are not required to make contributions from their salaries - are "out of touch" with the plans available to average Iowans, ... House Speaker Kraig Paulsen, R-Hiawatha, said.

18 Jan 2012

'Pro-survival' protein inhibitors may improve outlook for AML patients

Melbourne researchers have discovered that acute myeloid leukaemia (AML), an aggressive blood cancer with poor prognosis, may be susceptible to medications that target a protein called Mcl-1.

18 Jan 2012

Wis. company helps lead the way to digitizing health records

Operating on 800 acres of former farmland near Madison, Wis., Epic Systems supplies electronic records for large health care providers like the Cedars-Sinai Medical Center in Los Angeles ...

18 Jan 2012

Health influence of combustion conditions in wood-burning stoves

Wood-burning stoves are a popular source of heating in many countries. However in recent years there has been much debate about the potential negative health effects associated with wood smoke. A Norwegian researcher has studied the influence of combustion conditions on the emissions and their health effects.

18 Jan 2012

Scientists identify compound that can help repair toxic RNA defect

Scientists from the Florida campus of The Scripps Research Institute have identified a compound that can help repair a specific type of defect in RNA, a type of genetic material.

18 Jan 2012

Vitamin D supplements can fight against age-related macular degeneration

Researchers funded by the Biotechnology and Biological Sciences Research Council (BBSRC) have found that vitamin D reduces the effects of ageing in mouse eyes and improves the vision of older mice significantly. The researchers hope that this might mean that vitamin D supplements could provide a simple and effective way to combat age-related eye diseases, such as macular degeneration (AMD), in people.

17 Jan 2012

Researchers discover gene that causes benign familial infantile epilepsy

A team of Australian researchers has come a step closer to unlocking a mystery that causes epileptic seizures in babies.

17 Jan 2012

Insurance in the states: New York retailers often don't cover employees, HHS steps up scrutiny of Ariz. insurers

In New York City, a new study has found only three of 10 retail workers get health insurance through their job. In the meantime, the federal government is stepping up scrutiny of health insurers in Arizona, and Connecticut considers changes to appeal insurance company coverage denials.

17 Jan 2012

Chronology of Fetal Alcohol Syndrome revealed

It is known from studies that exposure to alcohol during gestation can cause a range of birth defects. But now scientists have drawn up a chronology of when the damage occurs.

17 Jan 2012